Re: RBC unregistered to registered account
|
6
|
Zenith Epigenetics
|
Apr 01, 2019 09:20PM
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
6
|
Resverlogix Corp.
|
Nov 01, 2021 09:45AM
|
Re: Question for the board!
|
6
|
Zenith Epigenetics
|
Jan 22, 2019 04:23PM
|
Re: Breaking down the Webcast
|
6
|
Resverlogix Corp.
|
Oct 24, 2019 01:54PM
|
Re: Don's April 14th Interview on the Drive
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 11:45AM
|
Re: Warning: Long - Thoughts on Management
|
6
|
Resverlogix Corp.
|
Mar 25, 2021 06:29PM
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
6
|
Resverlogix Corp.
|
May 09, 2022 01:10PM
|
Promissory Note
|
6
|
Zenith Epigenetics
|
Mar 09, 2021 04:20PM
|
Re: Zenith a Loser Too
|
6
|
Resverlogix Corp.
|
Jun 17, 2020 10:52AM
|
Re: Name Confusion
|
6
|
Zenith Epigenetics
|
Aug 12, 2020 12:16PM
|
Re: Don's April 14th Interview on the Drive
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 01:16PM
|
Re: ZHCLF trades on the OTC
|
6
|
Zenith Epigenetics
|
Jan 21, 2021 03:03PM
|
Re: A Special Meeting of Shareholders?
|
6
|
Resverlogix Corp.
|
May 30, 2024 03:55PM
|
clinicaltrials.gov
|
6
|
Resverlogix Corp.
|
May 15, 2021 03:04PM
|
Re: I am looking forward to Dec 4th...
|
6
|
Resverlogix Corp.
|
Nov 02, 2019 02:16AM
|
Re: Probably one of the most important days for RVX
|
6
|
Resverlogix Corp.
|
Nov 13, 2019 12:44PM
|
Re: Zenith-Oncology Pipeline
|
6
|
Zenith Epigenetics
|
Mar 18, 2021 04:01PM
|
Re: Trial delay
|
6
|
Resverlogix Corp.
|
May 04, 2021 12:02PM
|
Re: Sounds like great news!
|
6
|
Resverlogix Corp.
|
Feb 18, 2020 11:12PM
|
Zenith Royalties
|
6
|
Resverlogix Corp.
|
Jun 22, 2023 02:07PM
|